Search

Your search keyword '"Vasina V"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Vasina V" Remove constraint Author: "Vasina V"
101 results on '"Vasina V"'

Search Results

1. Barrier effect of Esoxx® on esophageal mucosal damage: experimental study on ex-vivo swine model

7. The Reverse Side of Digitalization: Polarization of The Russian Labor Market in The Process of Its Structural Transformation

8. PRINCIPLES OF PERSONNEL PLANNING IN THE CONDITIONS OF DIGITALIZATION OF THE ECONOMY

9. HUMAN CAPITAL MANAGEMENT WITHIN THE DIGITAL TRANSFORMATION OF AN INDUSTRIAL ENTERPRISE

10. Human Capital Development in the Conditions of the Russian Economy Digitalization

13. Development of an Approach to Assessment of Computerization Probability of Personnel Functions

14. DEVELOPMENT OF HUMAN CAPITAL OF INDUSTRIAL ENTERPRISE IN THE CONDITIONS OF DIGITALIZATION

15. Развитие человеческого капитала промышленного предприятия в условиях цифровизации

19. Prokinetics in the treatment of acute intestinal pseudo-obstruction

20. OC.05.4: MUCOSAL MEDIATORS FROM PATIENTS WITH IRRITABLE BOWEL SYNDROME STIMULATE ENTERIC CHOLINERGIC MOTOR NEURONS IN VITRO VIA PURINERGIC, PROSTAGLANDIN, AND TRPV1 PATHWAYS

30. Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.

31. The β3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats.

33. Intestinal Serotonin Release, Sensory Neuron Activation, and Abdominal Pain in Irritable Bowel Syndrome

34. Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats

35. The β3-adrenoceptor as a therapeutic target: Current perspectives

36. The hERG K+ channel: target and antitarget strategies in drug development

37. Antibacterial macrolides: a drug class with a complex pharmacological profile

38. Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A

39. Barrier effect of Esoxx on oesophageal mucosal damage: experimental study on ex-vivo swine model

40. Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats

42. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy

43. Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats

44. The beta-3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats

46. Farmaci lassativi e purganti

48. Comparison of Vaginal microbiota in HPV-negative and HPV-positive pregnant women using a culture-based approach.

49. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.

50. Animal models of chemically induced intestinal inflammation: predictivity and ethical issues.

Catalog

Books, media, physical & digital resources